CARAWAY’S INTEGRATED DRUG DISCOVERY PLATFORM
Clearance of toxic cellular components, whether they are damaged organelles, aggregated proteins, or accumulated lipids, is a fundamental function required for cell health. Mutations that impair cellular clearance pathways are associated with multiple neurodegenerative and rare diseases, including neurodegenerative disorders characterized by cognitive dysfunction. Caraway’s targeted approach combines genetic data and unique biological understanding to discover small molecules that activate cells’ clean-up and recycling processes thereby accelerating clearance of toxic materials and defective cellular components